Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,250
+20 (0.16%)
Nov 20, 2025, 3:30 PM KST

Oncocross Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
146,97975,179----
Enterprise Value
131,01762,376----
Last Close Price
12230.006340.00----
PS Ratio
141.5670.12----
PB Ratio
8.573.68----
P/TBV Ratio
8.593.68----
EV/Sales Ratio
126.1958.18----
Debt / Equity Ratio
0.020.030.010.050.20-1.14
Asset Turnover
0.060.050.010.010.01-
Quick Ratio
14.8111.3515.164.477.871.05
Current Ratio
14.8811.4215.254.597.931.06
Return on Equity (ROE)
-49.39%-35.10%-36.33%-114.08%--
Return on Assets (ROA)
-30.09%-21.69%-32.76%-53.18%-27.13%-
Return on Capital (ROIC)
-32.00%-23.15%-36.02%-61.28%-60.40%-
Return on Capital Employed (ROCE)
-47.00%-33.60%-41.30%-146.40%-55.20%-201.70%
Earnings Yield
-5.21%-8.62%----
FCF Yield
-5.14%-7.56%----
Buyback Yield / Dilution
-15.62%-17.49%-1.44%-63.74%-0.83%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.